Document:

Exhibit 4.4

       

      

      WARRANT AGREEMENT

       

      THIS WARRANT AGREEMENT (this “Agreement”), dated as of [●], 2021, is by and between Jackson Acquisition Company, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent,” also referred to herein as the “Transfer Agent”).

       

      WHEREAS, on [●], 2021, the Company entered into that certain Sponsor Warrants Purchase Agreement with RJ Healthcare SPAC, LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor will purchase an aggregate of 9,560,000 warrants (or up to 10,610,000 warrants if the Over-allotment Option (as defined below) in connection with the Company’s Offering (as defined below) is
        exercised in full) simultaneously with the closing of the Offering (and the closing of the Over-allotment Option, if applicable), bearing the legend set forth in Exhibit B hereto (the “Private Placement
          Warrants”, which term includes up to 1,500,000 additional Private Placement Warrants that may be issued upon conversion of Working Capital Loans (as defined below), as described in the next paragraph) at a purchase price of $1.00 per
        Private Placement Warrant. Each Private Placement Warrant entitles the holder thereof to purchase one share of Common Stock (as defined below) at a price of $11.50 per share, subject to adjustment as described herein;

       

      WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial merger, share exchange, asset acquisition, stock purchase, reorganization or similar business
        combination, involving the Company and one or more businesses (a “Business Combination”), the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not
        obligated to, loan the Company funds as the Company may require (“Working Capital Loans”), of which up to $1,500,000 of such loans may be convertible into up to an additional 1,500,000 Private Placement
        Warrants at a price of $1.00 per Private Placement Warrant;

       

      WHEREAS, the Company is engaged in an initial public offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised of one
        share of Common Stock (as defined below) and one-half of one Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and deliver up to 11,500,000 warrants
        (including up to 1,500,000 warrants subject to the Over-allotment Option (as defined below)) to public investors in the Offering (the “Public Warrants” and, together with the Private Placement Warrants, the “Warrants”). Each whole Warrant entitles the holder thereof to purchase one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), for
        $11.50 per share, subject to adjustment as described herein. Only whole Warrants are exercisable. A holder of the Warrants will not be able to exercise any fraction of a Warrant;

       

      WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No. 333-254727,
        including the prospectus contained therein (the “Prospectus”), for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the Units,
        the Public Warrants and the Common Stock included in the Units (such shares of Common Stock included in the Units, the “Public Shares”);

       

      WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange,
        redemption and exercise of the Warrants;

       

      WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and
        immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

       

      
        
          

      

      
      WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as
        provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

       

      NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

       

      1.                  Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and
        agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

       

      2.                  Warrants.

       

      2.1             Form of Warrant. Each Warrant shall be issued in registered form only.

       

      2.2             Effect of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid
        and of no effect and may not be exercised by the holder thereof.

       

      2.3              Registration.

       

      2.3.1        Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of original issuance and the
        registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with
        instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants in book-entry form shall be shown on, and the transfer of such ownership shall be effected through, records maintained by
        institutions that have accounts with The Depository Trust Company (the “Depositary”) (such institution, with respect to a Warrant in its account, a “Participant”).

       

      If the Depositary subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for
        book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to
        deliver to the Warrant Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants, which shall be in the
        form annexed hereto as Exhibit A.

       

      Physical certificates, if issued, shall be signed by, or bear the manual or facsimile signature of, the Chairman of the Company’s Board of Directors (the “Board”),

        Chief Executive Officer, President, Chief Financial Officer, Chief Accounting Officer, any Vice President, Treasurer or Secretary of the Company. In the event the person whose manual or facsimile signature has been placed upon any Warrant shall
        have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

       

      2.3.2        Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such
        Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other
        writing on any physical certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to
        the contrary.

       

      
        2

        
          

      

      2.4              Detachability of Warrants. The Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus or,
        if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business (a “Business Day”), then on the immediately
        succeeding Business Day following such date or earlier (the “Detachment Date”) with the consent of BofA Securities, Inc., but in no event shall the Common Stock and the Public Warrants comprising the Units be
        separately traded until (A) the Company has filed a current report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds received by
        the Company from the exercise by the underwriter of its right to purchase additional Units in the Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the filing of the
        Form 8-K, and (B) the Company issues a press release announcing when such separate trading shall begin. The Company will file the Form 8-K referred to in clause (A) of the preceding sentence promptly after the closing of the Offering and, if the
        Over-allotment Option is exercised following the filing of the initial Form 8-K, the Company will promptly file a second or amended current report on Form 8-K to provide updated financial information reflecting the exercise of the Over-allotment
        Option. Additionally, the Units will automatically separate into their component parts and will not be traded after completion of the initial Business Combination.

       

      2.5              No Fractional Warrants Other Than as Part of the Units. The Company shall not issue fractional Warrants other than as part of the Units, each of which is comprised of one
        share of Common Stock and one-half of one Public Warrant. If, upon the detachment of Public Warrants from the Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest
        whole number the number of Warrants to be issued to such holder.

      

      

      2.6              Private Placement Warrants. The Private Placement Warrants shall be identical to the Public Warrants, except that so long as they are held by the Sponsor or any of its
        Permitted Transferees (as defined below), the Private Placement Warrants: (i) may be exercised for cash or on a “cashless basis,” pursuant to subsection 3.3.1(c) hereof, (ii) including the shares of Common Stock issued or issuable upon
        exercise of the Private Placement Warrants, may not be transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination, (iii) shall only be redeemable by the Company pursuant to Section

          6.2 if the Reference Value (as defined below) is less than $18.00 per share (subject to adjustment in accordance with Section 4 hereof) and (iv) shall not be redeemable by the Company pursuant to Section 6.1 hereof; provided,
        however, that in the case of (ii), the Private Placement Warrants and any shares of Common Stock issued upon exercise of the Private Placement Warrants held by the Sponsor or any of its Permitted Transferees may be transferred by the holders
        thereof:

       

      (a)               to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, the Sponsor, any members of the Sponsor, or any affiliates
        of the Sponsor;

       

      (b)               in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, or
        an affiliate of such person or to a charitable organization;

       

      (c)               in the case of an individual, by virtue of the laws of descent and distribution upon death of the individual;

       

      (d)               in the case of an individual, pursuant to a qualified domestic relations order;

       

      
        3

        
          

      

      (e)               by private sales or transfers made in connection with the consummation of the Company’s initial Business Combination at prices no greater than the price at which the securities
        were originally purchased;

       

      (f)                in the event of the Company’s liquidation prior to the completion of the Company’s initial Business Combination;

       

      (g)               by virtue of the laws of the State of Delaware or the Sponsor’s limited liability company agreement upon dissolution of the Sponsor; or

       

      (h)               in the event of the Company’s completion of a liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of the holders of the
        Company’s Public Shares having the right to exchange their shares of Common Stock for cash, securities or other property subsequent to the completion of the Company’s initial Business Combination;

       

      (the transferees referred to in clauses (a) through (h) above are hereinafter called the “Permitted Transferees”); provided, however, that in the case of clauses (a) through
        (e) and clause (g), these Permitted Transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other provisions of the letter agreement dated as of [•], 2021 among the Company, the Sponsor and the
        officers and directors/director nominees of the Company party thereto and deliver such written agreement to the Company prior to or concurrently with the applicable transfer.

      

      

      3.                  Terms and Exercise of Warrants.

       

      3.1          Warrant Price. Each Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number
        of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement
        shall mean the price per share (including in cash or by payment of Warrants pursuant to a “cashless exercise,” to the extent permitted hereunder) at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in
        its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days (unless otherwise required by the Commission, any national securities exchange on
        which the Warrants are listed or applicable law); provided, that the Company shall provide at least three (3) Business Days prior written notice of such reduction to Registered Holders of the Warrants and, provided further that any
        such reduction shall be identical among all of the Warrants.

       

      3.2              Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”) commencing on the later of: (i) the
        date that is thirty (30) days after the date on which the Company completes its initial Business Combination, and (ii) the date that is twelve (12) months from the date of the closing of the Offering, and terminating at 5:00 p.m., New York City
        time, on the earliest to occur of: (x) the date that is five (5) years after the date on which the Company completes its initial Business Combination, (y) the liquidation of the Company in accordance with its amended and restated certificate of
        incorporation if the Company fails to complete its initial Business Combination, and (z) other than with respect to the Private Placement Warrants then held by the Sponsor or any Permitted Transferees with respect to a redemption pursuant to Section

          6.1 hereof or, if the Reference Value (as defined in Section 6.3 below) equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section 6.2 hereof (each, an “Inapplicable Redemption”), 5:00 p.m., New York City time, on the Redemption Date (as defined below) as provided in Section 6.3 hereof (the “Expiration Date”); provided, however,
        that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below, with respect to an effective registration statement under the Securities Act or a valid exemption
        from registration being available. Except with respect to the right to receive the Redemption Price (as defined below) (other than with respect to Private Placement Warrants then held by the Sponsor or any Permitted Transferees in the case of an
        Inapplicable Redemption), each Warrant (other than a Private Placement Warrant then held by the Sponsor or any Permitted Transferees with respect to an Inapplicable Redemption) not exercised on or before the Expiration Date shall become void, and
        all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time, on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration
        Date; provided, that the Company shall provide at least twenty (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in duration
        among all the Warrants.

       

      
        4

        
          

      

      3.3              Exercise of Warrants.

       

      3.3.1        Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by surrendering it, at the office of the
        Warrant Agent, or at the office of its successor as Warrant Agent with the subscription form, as set forth in the Warrant, duly executed (or, in the case of a Warrant in book-entry form, by delivering the Warrant and providing the information on
        the subscription form in accordance with the Depositary’s procedures), and by paying in full the Warrant Price for each full share of Common Stock as to which the Warrant is exercised (including by cashless exercise) and any and all applicable
        taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

       

      (a)               in lawful money of the United States, in good certified check or wire payable to the Warrant Agent;

       

      (b)               [Reserved];

       

      (c)               with respect to any Private Placement Warrant, so long as such Private Placement Warrant is held by the Sponsor or a Permitted Transferee, by surrendering the Warrants for that
        number of shares of Common Stock equal to (i) if in connection with a redemption of Private Placement Warrants pursuant to Section 6.2 hereof, as provided in Section 6.2 hereof with respect to a Make-Whole Exercise (as defined
        below) and (ii) in all other scenarios, the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Sponsor Exercise Fair Market Value” (as defined in this subsection

          3.3.1(c)) less the Warrant Price by (y) the Sponsor Exercise Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Sponsor Fair Market Value” shall mean the average last reported sale price of the shares of Common
        Stock for the ten (10) trading days ending on the third (3rd) trading day prior to the date on which notice of exercise of the Private Placement Warrant is sent to the Warrant Agent;

       

      (d)               as provided in Section 6.2 hereof with respect to a Make-Whole Exercise; or

       

      (e)               as provided in Section 7.4 hereof.

       

      3.3.2        Issuance of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if
        payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he, she or it is
        entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock
        as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any shares of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such
        Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying
        its obligations under Section 7.4 or unless a valid exemption from registration is available. No Warrant shall be exercisable and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the
        Common Stock issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. Subject to Section

          4.6, a Registered Holder of Warrants may exercise its Warrants only for a whole number of shares of Common Stock. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4.
        If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round down to the
        nearest whole number, the number of shares of Common Stock to be issued to such holder.

       

      
        5

        
          

      

      3.3.3        Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and
        non-assessable.

       

      3.3.4        Date of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued shall for all purposes be deemed to have
        become the holder of record of such shares of Common Stock on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such
        certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to
        have become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books or book-entry system are open.

       

      3.3.5        Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this subsection 3.3.5;
        however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such
        holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of
        9.8% or such other amount as the holder may specify (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing
        sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of the Warrant with respect to which the determination of such
        sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of
        the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a
        limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the
        Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding shares of Common Stock, the holder may rely on the number of outstanding
        shares of Common Stock as reflected in (1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with the Commission as the case may be, (2) a more recent public
        announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company
        shall, within two (2) Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
        conversion or exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the holder of a Warrant may
        from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st)
        day after such notice is delivered to the Company.

       

      
        6

        
          

      

      4.                  Adjustments.

       

      4.1              Stock Dividends.

       

      4.1.1        Split-Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding shares of Common Stock is increased by a stock
        dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise
        of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering made to all or substantially all holders of the Common Stock entitling holders to purchase shares of Common Stock at a
        price less than the “Historical Fair Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares of Common Stock actually sold in such rights offering (or
        issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Common Stock) multiplied by (ii) one (1) minus the quotient of (x) the price per share of Common Stock paid in such rights offering
        divided by (y) the Historical Fair Market Value. For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common Stock, there
        shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Historical Fair Market Value” means the volume weighted average price of the Common Stock during
        the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

       

      4.1.2        Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, pays to all or substantially all of the holders of shares of Common Stock
        a dividend or makes a distribution in cash, securities or other assets to the holders of the Common Stock on account of such shares of Common Stock (or other securities into which the Warrants are convertible), other than (a) as described in subsection

          4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of the Common Stock in connection with a proposed initial Business Combination, (d) to satisfy the redemption rights of the
        holders of Common Stock in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption of Public Shares in
        connection with the Company’s initial Business Combination or redeem 100% of the Public Shares  if the Company does not complete the Business Combination within the time period required by the Company’s amended and restated certificate of
        incorporation, as amended from time to time or (B) with respect to any other provision of the Company’s amended and restated certificate of incorporation relating to stockholders’ rights or pre-initial Business Combination activity, or (e) in
        connection with the redemption of Public Shares upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded event being referred to herein as
        an “Extraordinary Dividend’), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount
        of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share basis with the per share amounts of all other cash dividends and cash distributions paid on the Common
        Stock during the 365-day period ending on the date of declaration of such dividend or distribution, does not exceed $0.50 (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 but
        excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant), but only with respect to the amount of the aggregate cash dividends
        and cash distributions equal to or less than $0.50 per share (as adjusted if applicable).

       

      
        7

        
          

      

      4.2              Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of outstanding shares of Common Stock is decreased
        by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the
        number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common Stock.

       

      4.3              Adjustments in Warrant Price. Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1
        or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock
        purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter.

       

      4.4              Raising of the Capital in Connection with the Initial Business Combination. If (x) the Company issues additional shares of Common Stock or securities that are convertible
        into or exchangeable or exercisable for Common Stock for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such
        issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any shares of Class B common stock, par value $0.0001 per share, of
        the Company held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total
        equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of the Company’s initial Business Combination (net of redemptions), and (z) the volume-weighted average per
        share trading price of Common Stock during the twenty (20) trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market
          Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described in Section

          6.1 shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described in Section 6.2 shall be adjusted (to the nearest cent) to
        be equal to the higher of the Market Value and the Newly Issued Price.

      

      

      
        8

        
          

      

      4.5             Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change under subsections

          4.1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another corporation or entity (other than a
        consolidation or merger in which the Company is the continuing corporation or entity and that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another
        corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and
        receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the
        kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such
        sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrants immediately prior to such event (the “Alternative Issuance”); provided, however,
        that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or
        other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such consolidation or
        merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in
        connection with redemption rights held by stockholders of the Company as provided for in the Company’s amended and restated certificate of incorporation or as a result of the redemption of shares of Common Stock by the Company if a proposed initial
        Business Combination is presented to the stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule
        13d-5(b)(1) under the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members
        of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common Stock, the holder of a
        Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant
        prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of
        such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided, further, that if less than 70% of the consideration receivable by the holders of the Common Stock
        in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted
        immediately following such event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form
        8-K filed with the Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no
        event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event
        based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (assuming zero dividends) (“Bloomberg”). For purposes of calculating such amount, (1) Section 6 of
        this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the
        effective date of the applicable event, (3) the assumed volatility shall be the ninety (90) day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the
        applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the
        consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the amount of cash per share of Common Stock, if any, paid to the holders plus the
        volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change
        in shares of Common Stock covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4, as applicable. The provisions of this Section

          4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the
        Warrant.

       

      
        9

        
          

      

      4.6              Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Warrant, the Company shall
        give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of
        a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Section 4.1, 4.2, 4.3, 4.4 , 4.5, or 4.9
        the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such
        notice, or any defect therein, shall not affect the legality or validity of such event.

       

      4.7              No Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common Stock upon the
        exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such
        exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

       

      4.8          Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the
        same Warrant Price and the same number of shares of Common Stock as is stated in the Warrants initially issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in
        the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the
        form as so changed.

       

      4.9              Other Events. In case any event shall occur affecting the Company as to which none of the provisions of the preceding subsections of this Section 4 are strictly
        applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall
        appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to
        effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment; provided, however, that under no circumstances shall the Warrants be adjusted pursuant
        to this Section 4.9 as a result of any issuance of securities in connection with a Business Combination. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

       

      5.                  Transfer and Exchange of Warrants.

       

      5.1             Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such
        Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the
        old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

       

      
        10

        
          

      

      5.2             Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant
        Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event that a
        Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received an
        opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

       

      5.3             Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a warrant certificate or
        book-entry position for a fraction of a warrant, except as part of the Units.

       

      5.4             Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

       

      5.5             Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants
        required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

       

      5.6              Transfer of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and
        only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit.
        Notwithstanding the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the Detachment Date.

       

      6.                  Redemption.

       

      6.1              Redemption of Warrants for Cash. Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any
        time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.01 per Warrant, provided that (a) the
        Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof) and (b) there is an effective registration statement under the Securities Act covering the issuance of the shares of Common Stock
        issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.3 below).

       

      
        11

        
          

      

      6.2              Redemption of Warrants for Common Stock. Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company,
        at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Warrant, provided that
        (i) the Reference Value equals or exceeds $10.00 per share (subject to adjustment in compliance with Section 4 hereof) and (ii) if the Reference Value is less than $18.00 per share (subject to adjustment in compliance with Section 4
        hereof), the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. During the 30-day Redemption Period in connection with a redemption pursuant to this Section 6.2,
        Registered Holders of the Warrants may elect to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1 and receive a number of shares of Common Stock determined by reference to the table below, based on the Redemption
        Date (calculated for purposes of the table as the period to expiration of the Warrants) and the “Redemption Fair Market Value” (as such term is defined in this Section 6.2) (a “Make-Whole Exercise”).
        Solely for purposes of this Section 6.2, the “Redemption Fair Market Value” shall mean the volume weighted average price of the shares of Common Stock for the ten (10) trading days immediately
        following the date on which notice of redemption pursuant to this Section 6.2 is sent to the Registered Holders. In connection with any redemption pursuant to this Section 6.2, the Company shall provide the Registered Holders with
        the Redemption Fair Market Value no later than one (1) Business Day after the ten (10) trading day period described above ends.

       

      	 	
               

            	
              Redemption Fair Market Value of Common Stock ($)

            	
               

            
	
              
                Redemption Date (period to expiration of Warrants)

              

            	
              
                 

              

            	
              
                 

              

            	
              
                <10.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                11.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                12.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                13.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                14.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                15.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                16.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                17.00

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                ≥18.00

              

            	
              
                 

              

            
	
              
                60 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.261

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.281

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.297

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.311

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.324

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.337

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.348

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.358

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                57 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.257

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.277

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.294

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.310

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.324

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.337

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.348

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.358

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                54 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.252

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.272

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.291

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.307

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.322

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.335

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.347

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.357

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                51 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.246

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.268

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.287

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.304

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.320

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.333

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.346

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.357

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                48 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.241

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.263

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.283

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.301

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.317

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.332

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.344

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.356

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                45 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.235

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.258

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.279

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.298

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.315

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.330

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.343

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.356

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                42 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.228

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.252

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.274

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.294

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.312

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.328

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.342

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.355

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                39 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.221

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.246

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.269

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.290

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.309

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.325

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.340

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.354

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                36 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.213

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.239

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.263

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.285

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.305

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.323

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.339

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.353

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                33 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.205

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.232

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.257

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.280

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.301

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.320

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.337

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.352

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                30 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.196

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.224

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.250

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.274

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.297

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.316

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.335

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.351

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                27 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.185

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.214

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.242

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.268

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.291

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.313

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.332

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.350

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                24 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.173

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.204

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.233

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.260

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.285

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.308

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.329

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.348

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                21 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.161

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.193

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.223

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.252

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.279

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.304

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.326

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.347

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                18 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.146

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.179

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.211

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.242

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.271

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.298

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.322

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.345

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                15 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.130

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.164

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.197

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.230

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.262

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.291

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.317

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.342

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                12 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.111

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.146

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.181

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.216

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.250

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.282

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.312

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.339

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                9 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.090

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.125

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.162

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.199

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.237

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.272

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.305

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.336

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                6 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.065

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.099

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.137

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.178

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.219

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.259

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.296

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.331

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                3 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.034

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.065

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.104

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.150

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.197

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.243

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.286

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.326

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            
	
              
                0 months

              

            	
              
                 

              

            	
              
                 

              

            	
              
                —

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                —

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.042

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.115

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.179

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.233

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.281

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.323

              

            	
              
                 

              

            	
              
                 

              

            	
              
                 

              

            	
              
                0.361

              

            	
              
                 

              

            

       

      
        12

        
          

      

      The exact Redemption Fair Market Value and Redemption Date may not be set forth in the table above, in which case, if the Redemption Fair Market Value is between two values in the table or the
        Redemption Date is between two redemption dates in the table, the number of shares of Common Stock to be issued for each Warrant exercised in a Make-Whole Exercise shall be determined by a straight-line interpolation between the number of shares
        set forth for the higher and lower Redemption Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365- or 366-day year, as applicable.

       

      The stock prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of a Warrant or the Warrant Price is
        adjusted pursuant to Section 4 hereof. If the number of shares issuable upon exercise of a Warrant is adjusted pursuant to Section 4 hereof, the adjusted share prices in the column headings shall equal the share prices immediately
        prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon
        exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a Warrant. If the Warrant Price is adjusted, (a) in the case
        of an adjustment pursuant to Section 4.4 hereof, the adjusted share prices in the column headings shall equal the share prices immediately prior to such adjustment multiplied by a fraction, the numerator of which is the higher of the Market
        Value and the Newly Issued Price and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to Section 4.1.2 hereof, the adjusted share prices in the column headings shall equal the share prices immediately prior
        to such adjustment less the decrease in the Warrant Price pursuant to such Warrant Price adjustment. In no event shall the Warrants be exercisable in connection with a Make-Whole Exercise for more than 0.361 shares of Common Stock per Warrant
        (subject to adjustment). In the event that the stock prices set forth under the column headings of the above table are adjusted as provided in the preceding sentences of this paragraph, then the references to “0.361” appearing in the immediately
        preceding sentence and in subsection 7.4.1 shall be simultaneously adjusted to be equal to the number appearing in the $18.00 column of such table immediately after giving effect to such adjustment to the stock prices in such table; and, in
        the event that the stock prices set forth under the column headings of such table are subsequently adjusted as provided in the preceding sentences of this paragraph, then the number in the immediately preceding sentence and in subsection 7.4.1
        shall again be adjusted as provided in this sentence.

       

      6.3          Date Fixed for, and Notice of, Redemption; Redemption Price; Reference Value. In the event that the Company elects to redeem the Warrants pursuant to Sections 6.1 or 6.2,
        the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the
        Redemption Date (the period lasting from such time until the Redemption Date, the “30-day Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall
        appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered Holder received such notice. As used in this Agreement, (a) “Redemption Price” shall mean the price per Warrant at which any Warrants are redeemed pursuant to Sections 6.1 or 6.2 and (b) “Reference Value” shall mean
        the last reported sales price of the Common Stock for any twenty (20) trading days within the thirty (30) trading day period ending on the third trading day prior to the date on which notice of the redemption is given.

       

      
        13

        
          

      

      6.4              Exercise After Notice of Redemption. The Warrants may be exercised, for cash (or, if in connection with a redemption pursuant to Section 6.2 of this Agreement, on a
        “cashless basis” in accordance with such section) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.3 hereof and prior to the Redemption Date. On and after the Redemption Date, the Registered
        Holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price.

       

      6.5              Exclusion of Private Placement Warrants. The Company agrees that (a) the redemption rights provided in Section 6.1 hereof shall not apply to the Private Placement
        Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the Sponsor or its Permitted Transferees and (b) if the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section

          4 hereof), the redemption rights provided in Section 6.2 hereof shall not apply to the Private Placement Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the Sponsor or its Permitted
        Transferees. However, once such Private Placement Warrants are transferred (other than to Permitted Transferees in accordance with Section 2.6 hereof), the Company shall redeem the Private Placement Warrants pursuant to Section 6.1
        or 6.2 hereof, if the Company elects to redeem the Warrants pursuant to either such Section, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants to exercise the
        Private Placement Warrants prior to redemption pursuant to Section 6.4 hereof. Private Placement Warrants that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants and
        shall become Public Warrants under this Agreement, including for purposes of Section 9.8 hereof.

       

      7.                  Other Provisions Relating to Rights of Holders of Warrants.

       

      7.1              No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the
        right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other
        matter.

       

      7.2          Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or
        otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed.
        Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

       

      7.3              Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common Stock that shall be
        sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

       

      
        14

        
          

      

      7.4              Registration of Common Stock; Cashless Exercise at Company’s Option.

       

      7.4.1        Registration of the Common Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days after the closing of its initial
        Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the issuance of the shares of Common Stock issuable upon exercise of the
        Warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective within sixty (60) Business Days following the closing of its initial Business Combination and to maintain the effectiveness of such
        registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the
        sixtieth (60th) Business Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the sixty-first (61st) Business Day after the closing of the Business Combination and
        ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement covering the issuance of shares of Common Stock
        issuable upon exercise of the Warrants and a current prospectus relating thereto, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any successor thereto) or
        another exemption) for that number of shares of Common Stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market
        Value” (as defined below) less the Warrant Price by (y) the Fair Market Value and (B) the product of 0.361 multiplied by the number of shares of Common Stock underlying the Warrants. Solely for purposes of this subsection 7.4.1, “Fair
        Market Value” shall mean the volume-weighted average price of the Common Stock for the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants
        or its securities broker or intermediary. The date that notice of “cashless exercise” is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the
        Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) to the effect that (i) the exercise of the Warrants on a “cashless basis” in
        accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be tradable without registration under the Securities Act by anyone who is
        not an affiliate (as such term is defined in Rule 144 under the Securities Act) of the Company and, accordingly, shall not be required to bear a restrictive legend, or otherwise reasonably acceptable to the Warrant Agent. Except as provided in subsection

          7.4.2, for the avoidance of doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection

          7.4.1.  At such time as the Warrants become exercisable for a security other than shares of Common Stock, the Company (or, if applicable, the successor or surviving entity) will use its commercially reasonable efforts to register under the
        Securities Act the security issuable upon the exercise of the Warrants.

       

      7.4.2        Cashless Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange such that it does not
        satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor thereto), the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such Public
        Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or any successor thereto) as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file
        or maintain in effect a registration statement for the registration, under the Securities Act, of the Common Stock issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its commercially
        reasonable efforts to register or qualify for sale the Common Stock issuable upon exercise of the Public Warrant under applicable blue sky laws to the extent an exemption is not available. Upon receipt of a notice of exercise for a cashless
        exercise the Company will promptly calculate and transmit to the Warrant Agent the number of shares of Common Stock issuable in connection with such cashless exercise and deliver a copy of the notice of exercise to the Warrant Agent, which shall
        issue such number of shares of Common Stock in connection with such cashless exercise.

      

      

      
        15

        
          

      

      7.4.3        State Securities Laws. Anything herein to the contrary notwithstanding, the Company will use its commercially reasonable efforts to register or qualify the Common Stock
        issuable upon the exercise of the Warrants under applicable state securities laws to the extent an exemption from such registration or qualification is not available (including, without limitation, the exemption available so long as the Common
        Stock is a “covered security” under (A) Section 18(b)(1) of the Securities Act or (B) solely in the case of shares of Common Stock being issued upon cashless exercise of a Warrant (if such cashless exercise is permitted under this Agreement),
        Section 18(b)(4)(E) of the Securities Act, provided that, in the case of this clause (B), such Warrant is being exercised pursuant and in accordance with Section 3(a)(9) of the Securities Act).

      

      

      8.                  Concerning the Warrant Agent and Other Matters.

       

      8.1              Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the
        issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares of Common Stock.

       

      8.2              Resignation, Consolidation, or Merger of Warrant Agent.

       

      8.2.1        Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and
        liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent
        in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who
        shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the
        Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough
        of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with
        all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary
        or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder;
        and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such
        authority, powers, rights, immunities, duties, and obligations.

       

      
        16

        
          

      

      8.2.2        Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the
        Transfer Agent for the Common Stock not later than the effective date of any such appointment.

       

      8.2.3        Merger or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any entity resulting from any merger or
        consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act.

       

      8.3              Fees and Expenses of Warrant Agent.

       

      8.3.1        Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant to its obligations under
        this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

       

      8.3.2        Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other
        acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.

       

      8.4              Liability of Warrant Agent.

       

      8.4.1        Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or matter be
        proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a
        statement signed by the Chief Executive Officer, President, Chief Financial Officer, Secretary or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or
        suffered in good faith by it pursuant to the provisions of this Agreement.

       

      8.4.2        Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad faith. The Company agrees to indemnify the Warrant
        Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of
        the Warrant Agent’s gross negligence, willful misconduct, fraud or bad faith.

       

      8.4.3        Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except
        its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments
        required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act
        hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued,
        be valid and fully paid and non-assessable.

       

      
        17

        
          

      

      8.5              Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set
        forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through
        the exercise of the Warrants.

       

      8.6              Waiver. The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any
        distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse,
        reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

       

      9.                  Miscellaneous Provisions.

       

      9.1          Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective
        successors and assigns.

       

      9.2          Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be
        sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
        by the Company with the Warrant Agent), as follows:

       

      Jackson Acquisition Company

      2655 Northwinds Parkway

      Alpharetta, GA 30009

      Attention: Richard L. Jackson

       

      Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so
        delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with
        the Company), as follows:

       

      Continental Stock Transfer & Trust Company

      1 State Street, 30 FL

      New York, New York 10004

      Attn:          Compliance Department

       

      9.3          Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York.
        Subject to applicable law, the Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement, including under the Securities Act, shall be brought and enforced in the courts of the
        State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company hereby
        waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by
        the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum.

       

      
        18

        
          

      

      Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3. If
        any action, the subject matter of which is within the scope of the forum provisions above, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York in
        connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action
        by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

       

      9.4          Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation or other entity other than the
        parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises,
        and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants.

       

      9.5          Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough of Manhattan, City
        and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit such holder’s Warrant for inspection by it.

       

      9.6          Counterparts. This Agreement may be executed in any number of original or facsimile counterparts, and each of such counterparts shall for all purposes be deemed to be an
        original, and all such counterparts shall together constitute but one and the same instrument. The words “executed”, “execution,” “signed,” “signature,” and words of like import in this Agreement or in any certificate, agreement or document related
        to this Agreement shall include images of manually executed signatures transmitted by facsimile, email or other electronic format (including, without limitation, “pdf,” “tif” or “jpg”) but shall not include (nor shall this Agreement or any Warrant
        be executed or countersigned by means of) electronic signatures (including, without limitation, DocuSign and AdobeSign); provided that, notwithstanding the foregoing, certificates evidencing the Warrants may be signed by facsimile signature as
        provided in Section 2.3.1 hereof. The use of signatures transmitted electronically and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic
        means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in
        Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code.

       

      9.7          Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

       

      
        19

        
          

      

      9.8          Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of (i) curing any ambiguity or correcting any
        mistake, including conforming the provisions hereof to the description of the terms of the Warrants and this Agreement set forth in the Prospectus, or defective provision contained herein, or (ii) adding or changing any provisions with respect to
        matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the rights of the Registered Holders under this Agreement. All other modifications or amendments,
        including any modification or amendment to increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of only the Private Placement Warrants, shall require the vote or written consent of the Registered Holders of at
        least 65% of the then outstanding Public Warrants; provided that any amendment that solely affects the terms of the Private Placement Warrants or any provision of this Agreement solely with respect to the Private Placement Warrants shall
        also require at least 65% of the-then outstanding Private Placement Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2,
        respectively, without the consent of the Registered Holders.

       

      9.9          Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of
        this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
        such invalid or unenforceable provision as may be possible and be valid and enforceable.

       

      
        20

        
          

      

      IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

      

      

      	 	
              JACKSON ACQUISITION COMPANY

            
	 	 	 
	 	
              By:

            	 
	 	 	
              Name: Richard L. Jackson

            
	 	 	
              Title:   President and Chief Executive Officer

            
	 	 	 
	 	 	 
	 	
              CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

            
	 	 	 
	 	
              By:

            	 
	 	 	
              Name:

            
	 	 	
              Title:

            

      

      

      

      

      

      

      [Signature Page to Warrant Agreement]

      

      

      
        
          

      

      EXHIBIT A

       

      Form of Warrant Certificate

       

      
        
          

      

      [Face of Warrant Certificate]

      Number

      Warrants

       

      THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

        THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

        IN THE WARRANT AGREEMENT DESCRIBED BELOW

       

      JACKSON ACQUISITION COMPANY

       

      Incorporated Under the Laws of the State of Delaware

       CUSIP 46653C 114

      

      

      Warrant Certificate

       

      This Warrant Certificate certifies that ___________, or registered assigns, is the registered holder of ___________ warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase shares of Class A common stock, $0.0001 par value (“Common Stock”), of Jackson
        Acquisition Company, a Delaware corporation (the “Company”). Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to receive from the Company
        that number of fully paid and non-assessable shares of Common Stock as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful money
        (or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency
        of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

       

      Each Warrant is initially exercisable for one fully paid and non-assessable share of Common Stock. No fractional shares of Common Stock will be issued upon exercise of any Warrant. If, upon the
        exercise of Warrants, a holder would be entitled to receive a fractional interest in a share of Common Stock, the Company will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the Warrant
        holder. The number of shares of Common Stock issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

       

      The initial Exercise Price per share of Common Stock for any Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon the occurrence of certain events set forth in the
        Warrant Agreement.

       

      Subject to the conditions set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such
        Warrants shall become void. The Warrants may be redeemed, subject to certain conditions, as set forth in the Warrant Agreement.

       

      Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though
        fully set forth at this place.

       

      This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

       

      
        
          

      

      This Warrant Certificate shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.

      

      

      	
                

            	
              JACKSON ACQUISITION COMPANY

            
	
               

            	
               

            	
               

            	
               

            
	
               

            	
              By:

            	
               

            	
               

            
	
               

            	
               

            	
               

            	
              Name:

            
	
               

            	
               

            	
               

            	
              Title:

            
	
               

            	
               

            	
               

            
	
               

            	
              CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

            
	
               

            	
               

            	
               

            	
               

            
	
               

            	
              By:

            	
               

            	
               

            
	
               

            	
               

            	
               

            	
              Name:

            
	
               

            	
               

            	
               

            	
              Title:

            

      
        
          

      

      [Reverse of Warrant Certificate]

       

      The Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive shares of Common Stock and are issued or to be issued
        pursuant to a Warrant Agreement dated as of [●], 2021 (the “Warrant Agreement”), duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation, as
        warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of
        rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder” meaning the Registered Holders
        or Registered Holder, respectively) of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have the
        meanings given to them in the Warrant Agreement.

       

      Warrants may be exercised at any time during the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering
        this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in
        the Warrant Agreement) at the office of the Warrant Agent. In the event that upon any exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to
        the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.

       

      Notwithstanding anything else in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the issuance of
        the shares of Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating to the shares of Common Stock is current, except through “cashless exercise” as provided for in the Warrant
        Agreement or another exemption from registration under the Securities Act.

       

      The Warrant Agreement provides that upon the occurrence of certain events the number of shares of Common Stock issuable upon exercise of the Warrants set forth on the face hereof and the Exercise
        Price may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise, round down to the nearest
        whole number of shares of Common Stock to be issued to the holder of the Warrant.

       

      Warrant Certificates, when surrendered at the office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized in writing, may be
        exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of
        Warrants.

       

      Upon due presentation for registration of transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in
        the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge
        imposed in connection therewith.

       

      The Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing
        hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the
        Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

       

       

      
        
          

      

      Election to Purchase

      (To Be Executed Upon Exercise of Warrant)

       

      The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive _____________ shares of Common Stock and herewith tenders payment (which may be
        by cashless exercise) for such shares of Common Stock to the order of Jackson Acquisition Company (the “Company”) in the amount of $____________ in accordance with the terms hereof. The undersigned requests that a certificate for such shares of
        Common Stock be registered in the name of ___________________, whose address is _______________________ and that such shares of Common Stock be delivered to ___________________ whose address is _______________________. If said number of shares of
        Common Stock is less than all of the shares of Common Stock purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of
        _______________________, whose address is _______________________and that such Warrant Certificate be delivered to ___________________, whose address is _______________________.

       

      In the event that the Warrant has been called for redemption by the Company pursuant to Section 6.2 of the Warrant Agreement and a holder thereof elects to exercise its Warrant pursuant to
        a Make-Whole Exercise, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) or Section 6.2 of the Warrant Agreement, as applicable.

       

      In the event that the Warrant is a Private Placement Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the number of shares of
        Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) of the Warrant Agreement.

       

      In the event that the Warrant is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Common Stock that this Warrant is
        exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

       

      In the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, and is being exercised through cashless exercise (i) the number of shares of Common Stock that this
        Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably
        elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive shares of Common Stock. If said number of shares is less than all of the shares of Common Stock
        purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of ___________________, whose
        address is _______________________and that such Warrant Certificate be delivered to ___________________, whose address is _______________________.

       

      [Signature Page Follows]

       

       

      
        
          

      

      Date: ___________________, 20__

       

      	
               

            	
               

            
	
               

            	
               

            
	
               

            	
              (Signature)

            
	
               

            	
               

            
	
               

            	
               

            
	
               

            	
              (Address)

            
	
               

            	
               

            
	
               

            	
               

            
	
               

            	
              (Tax Identification Number)

            

      Signature Guaranteed:

       

      THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM,
        PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR RULE)).

       

       

      
        
          

      

      EXHIBIT B

       

      LEGEND

       

      “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF
        UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER
        AGREEMENT BY AND AMONG JACKSON ACQUISITION COMPANY (THE “COMPANY”), RJ HEALTHCARE SPAC, LLC AND THE OTHER PARTIES THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND THE SHARES OF CLASS A COMMON STOCK
        OF THE COMPANY ISSUABLE UPON EXERCISE OF SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN THE RECITALS OF THE
        WARRANT AGREEMENT BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT (THE “WARRANT AGREEMENT”)) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT
        AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

       

      SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE
        EXECUTED BY THE COMPANY.”

       

      	
               

            	
               

            	
               

            
	
              No.

            	
               

            	
              WarrantExhibit 10.2

    

    

    Jackson Acquisition Company

    2655 Northwinds Parkway

    Alpharetta, GA 30009

    Re: Initial Public Offering

    

    

    Ladies and Gentlemen:

    

    

    This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”)
      to be entered into by and between Jackson Acquisition Company, a Delaware corporation (the “Company”), and BofA Securities, Inc., as underwriter (the “Underwriter”),
      relating to an underwritten initial public offering (the “Public Offering”) of up to 23,000,000 of the Company’s units (the “Units”) (including up to 3,000,000 units that
      may be purchased to cover over-allotments, if any, at the option of the Underwriter (the “over-allotment option”)), each comprised of one share of the Company’s Class A common stock, par value $0.0001 per share
      (the “Common Stock”), and one-half of one redeemable warrant. Each whole warrant (a “Warrant”) entitles the holder thereof to purchase one share of Common Stock at a
      price of $11.50 per share, subject to adjustment. The Units will be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the “Prospectus”) filed by the Company with the
      U.S. Securities and Exchange Commission (the “Commission”), and the Company has applied to have the Units listed on the New York Stock Exchange. Certain capitalized terms used herein are defined in paragraph 11
      hereof.

    

    

    In order to induce the Company and the Underwriter to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt and sufficiency of which are
      hereby acknowledged, RJ Healthcare SPAC, LLC (the “Sponsor”) and each of the undersigned individuals, each of whom is a member of the Company’s board of directors and/or an officer of the Company (each, an “Insider” and collectively, the “Insiders”), each hereby severally (and not jointly) agrees with the Company as follows:

    

    

    1.          The Sponsor and each Insider agrees that if the Company seeks stockholder approval of a proposed Business Combination, then in connection with such proposed Business Combination, it, he or she shall (i) vote
      any shares of Capital Stock owned by it, him or her in favor of any proposed Business Combination and (ii) not redeem any shares of Capital Stock owned by it, him or her in connection with such stockholder approval. If the Company seeks to consummate
      a proposed Business Combination by engaging in a tender offer for Common Stock, the Sponsor and each Insider agrees that it, he or she will not sell or tender any shares of Capital Stock owned by it, him or her in connection therewith. As used in
      this Letter Agreement, references to Capital Stock, Warrants or other securities "owned" by any person or entity and similar references mean any direct or indirect legal, record or beneficial ownership.

    

    

    
      1

      
        

    

    

    

     

    2.          The Sponsor and each Insider hereby agrees that in the event that the Company fails to consummate its initial Business Combination within 18 months from the closing of the Public Offering (or within 21 months
      from the closing of the Public Offering if the Sponsor exercises its option to extend the period of time to complete the initial Business Combination in accordance with the terms of the Charter (as defined below)), or such later period approved by
      the Company’s stockholders in accordance with the Company’s amended and restated certificate of incorporation (the “Charter”), the Sponsor and each Insider shall take all reasonable steps to cause the Company
      to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, subject to lawfully available funds therefor, redeem 100% of the Common Stock sold as part of the
      Units in the Public Offering (the “Offering Shares”), at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of
      interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Offering Shares, which redemption will completely extinguish all Public Stockholders’ rights as stockholders
      (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the
      Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Sponsor and each Insider agree to not
      propose any amendment to the Charter (A) that would modify the substance or timing of the Company’s obligation to allow redemption of the Offering Shares in connection with the Company’s initial Business Combination or to redeem 100% of the Offering
      Shares if the Company does not complete its initial Business Combination within 18 months from the closing of the Public Offering (or within 21 months from the closing of the Public Offering if the Sponsor exercises its option to extend the period of
      time to complete the initial Business Combination in accordance with the terms of the Charter), or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides its
      Public Stockholders with the opportunity to redeem their Offering Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest
      shall be net of taxes payable), divided by the number of then issued and outstanding Offering Shares.

    

    

    The Sponsor and each Insider acknowledges and agrees that it, he or she has no right, title, interest or claim of any kind in or to any monies held in, or any liquidating distributions from, the Trust Account as a result
      of any liquidation of the Company with respect to the Founder Shares held by it, him or her at any time and, without limitation of the foregoing, waives any such right, title, interest or claim. The Sponsor and each Insider hereby further waives,
      with respect to any shares of Capital Stock held by it, him or her, if any, at any time, any redemption rights it, he or she may have in connection with (x) the consummation of a Business Combination, including, without limitation, any such rights
      available in the context of a stockholder vote to approve such Business Combination or in the context of a tender offer made by the Company to purchase shares of Common Stock and (y) a stockholder vote to approve an amendment to the Charter (i) to
      modify the substance or timing of the Company’s obligation to allow redemption of Offering Shares in connection with the Company’s initial Business Combination or to redeem 100% of the Offering Shares if the Company does not complete a Business
      Combination within 18 months from the closing of the Public Offering (or within 21 months from the closing of the Public Offering if the Sponsor exercises its option to extend the period of time to complete the initial Business Combination in
      accordance with the terms of the Charter) or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity (although the Sponsor, the Insiders and their respective affiliates shall be entitled
      to redemption and liquidation rights with respect to any Offering Shares it or they hold if the Company fails to consummate a Business Combination within 18 months from the closing of the Public Offering (or within 21 months from the closing of the
      Public Offering if the Sponsor exercises its option to extend the period of time to complete the initial Business Combination in accordance with the terms of the Charter)).

    

    

    
      2

      
        

    

    

    

     

    3.          Without limitation to the provisions set forth in paragraphs 7(a) and (b) below, during the period beginning on and including the date of the Underwriting Agreement through and including the day that is 180
      days after such date, the Sponsor and each Insider will not, without the prior written consent of the Underwriter, directly or indirectly, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
      contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of any Units, shares of Capital Stock, Warrants, Working Capital Warrants, Private Placement Warrants or other warrants of the Company or any
      securities convertible into, or exercisable or exchangeable for, Units, shares of Capital Stock, Warrants, Working Capital Warrants, Private Placement Warrants or other warrants of the Company, or file or confidentially submit or cause to be filed or
      confidentially submitted any registration statement under the Securities Act of 1933, as amended (the “Securities Act”), with respect to any of the foregoing securities or register any of the foregoing
      securities pursuant to a registration statement filed under the Securities Act , or publicly disclose any intention to undertake any of the foregoing, or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or
      in part, directly or indirectly, any of the economic consequences of ownership of any Units, shares of Capital Stock, Warrants, Working Capital Warrants, Private Placement Warrants or other warrants of the Company, whether any such swap, agreement or
      transaction described in clause (i) or (ii) above is to be settled by delivery of Units, shares of Capital Stock, Warrants, Working Capital Warrants, Private Placement Warrants, other warrants of the Company or other securities, in cash or otherwise.
      The foregoing sentence shall not apply to (A) the forfeiture of Founder Shares if the Underwriter does not exercise its over-allotment option in full, (B) any transfer of Founder Shares to any current or future independent directors of the Company
      (so long as each such current or future independent director is , at the time of such transfer, a party to this Letter Agreement or a written agreement (which may be an amendment or supplement to this Letter Agreement or a substantially identical
      agreement) delivered to the Company prior to such transfer agreeing to be bound by and comply with all of the terms and provisions of this Letter Agreement that are applicable to Insiders (including, without limitation, the transfer restrictions set
      forth in this paragraph 3 and paragraph 7 hereof), and making the representations and warranties set forth in this Letter Agreement that are made by Insiders; (C) any offer of securities that may be issued by the Company in connection with a Business
      Combination if such offer is made on behalf of the Company, or (D) any transfer of Founder Shares or Private Placement Warrants, or any shares of Common Stock issued or issuable upon the conversion of Founder Shares, to any Permitted Transferee (as
      defined below) described in, and in accordance with any of clauses (c), (d), (e), (f) or (h) of paragraph 7(c) hereof (provided, however, that , in the case of any transfer pursuant to any of clauses (c)-(e) of paragraph 7(c), the transferee is, at
      the time of such transfer, a party to this Letter Agreement or enters into and delivers to the Company, at or prior to the time of such transfer, a written agreement (which may be an amendment or supplement to this Letter Agreement or a substantially
      identical agreement) agreeing to be bound by and comply with all of the terms and provisions of this Letter Agreement that are applicable to Insiders (or, if such transferee is the Sponsor, that are applicable to the Sponsor) (including, without
      limitation, the transfer restrictions set forth in this paragraph 3 and paragraph 7 hereof), and, if such transferee is the Sponsor or an officer or director of the Company, making applicable representations and warranties set forth in this Letter
      Agreement; provided, however, that, to the extent that any reporting obligation under Section 16 of the Securities Exchange Act of 1934, as amended, is triggered as a result of any transfer described in clause (A), (B) or (D) of this sentence, any
      related filing under such Section 16 includes a practical explanation as to the nature of the transfer). "Working Capital Warrants" means any warrants to purchase capital stock issued by the Company upon the
      conversion of working capital loans (“Working Capital Loans”) made to the Company by the Sponsor, any Insiders, or their respective affiliates.

    

    

    
      3

      
        

    

    

    

     

    4.          In the event of the liquidation of the Trust Account, the Sponsor (which for purposes of clarification shall not extend to any other shareholders, members, officers or managers of the Sponsor) agrees to
      indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against
      any litigation, whether pending or threatened, or any claim whatsoever) to which the Company may become subject as a result of any claim by (i) any third party for services rendered (other than the Company’s independent registered public accountants)
      or products sold to the Company or (ii) a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”); provided, however, that such indemnification of the
      Company by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for services rendered (other than the Company’s independent registered public accountants) or products sold to the Company or a Target do not
      reduce the amount of funds in the Trust Account to below (i) $10.15 per Offering Share or (ii) such lesser amount per Offering Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of
      the trust assets (in each case, net of the amount of interest earned on the property in the Trust Account which may be withdrawn to pay taxes), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the
      Trust Account and except as to any claims under the Company’s indemnity of the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended, pursuant to the Underwriting Agreement. In the event that any
      such executed waiver is deemed to be unenforceable against such third party, the Sponsor shall not be responsible to the extent of any liability for such third party claims. The Sponsor shall have the right to defend against any such claim with
      counsel of its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Sponsor, the Sponsor notifies the Company in writing that it shall undertake such defense. For the avoidance of
      doubt, none of the Company’s officers of directors will indemnify the Company for claims by third parties, including, without limitation, claims by vendors and prospective Targets.

    

    

    5.          To the extent that the Underwriter does not exercise in full its over-allotment option to purchase up to an additional 3,000,000 Units within 45 days from the date of the Prospectus (as further described in
      the Prospectus), the Sponsor agrees to forfeit, at no cost, a number of Founder Shares in the aggregate equal to the product of 750,000 multiplied by a fraction, (i) the numerator of which is 3,000,000 minus the number of Units, if any, purchased by
      the Underwriter upon the exercise of its over-allotment option, and (ii) the denominator of which is 3,000,000. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the Underwriter so that the
      aggregate number of outstanding Founder Shares will equal 20.0% of the Company’s total issued and outstanding shares of Capital Stock after the Public Offering. To the extent that the size of the Public Offering is increased or decreased, the Company
      will effect a recapitalization or share repurchase, redemption or stock split or other appropriate mechanism, as applicable, immediately prior to the consummation of the Public Offering in such amount as to maintain the number of outstanding Founder
      Shares at 20.0% of the total number of issued and outstanding shares of Capital Stock upon the consummation of the Public Offering. In connection with such increase or decrease in the size of the Public Offering, (A) references to 3,000,000 in the
      numerator and denominator of the formula in the first sentence of this paragraph shall be changed to a number equal to 15% of the number of shares of Common Stock included in the Units issued in the Public Offering (assuming no exercise of the
      over-allotment option), and (B) the reference to 750,000 in the formula set forth in the first sentence of this paragraph shall be adjusted to such number of Founder Shares that the Sponsor would have to return to the Company in order to hold (with
      all of the other holders of Founder Shares) an aggregate of 20.0% of the total number of issued and outstanding shares of Capital Stock upon consummation of the Public Offering (assuming no exercise of the over-allotment option).

    

    

    6.          The Sponsor and each Insider hereby agrees and acknowledges that: (i) the Underwriter and the Company would be irreparably injured in the event of a breach by such Sponsor or an Insider of its, his or her
      obligations under paragraphs 1, 2, 3, 4, 5, 7(a), 7(b), and 9, as applicable, of this Letter Agreement, (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled, to the extent permitted
      by applicable law, injunctive relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach.

    

    

    
      4

      
        

    

    

    

     

    7.          (a) The Sponsor and each Insider agree that it, he or she shall not Transfer (as defined below) any Founder Shares (or shares of Common Stock issued or issuable upon conversion thereof) until the earlier of
      (A) one year after the completion of the Company’s initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Common Stock equals or exceeds $12.00 per share (as adjusted for stock
      splits, stock dividends, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y)
      the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of Common Stock for cash,
      securities or other property (the “Founder Shares Lock-up Period”).

    

    

    (b)          The Sponsor and each Insider agree that it, he or she shall not Transfer any Private Placement Warrants (or shares of Common Stock issued or issuable upon the exercise of the Private Placement Warrants)
      until 30 days after the completion of the initial Business Combination (the “Private Placement Warrants Lock-up Period”, together with the Founder Shares Lock-up Period, the “Lock-up
        Periods”).

    

    

    (c)          Notwithstanding the provisions set forth in paragraphs 7(a) and (b), Transfers of the Founder Shares, Private Placement Warrants and shares of Common Stock issued or issuable upon the exercise or conversion
      of the Private Placement Warrants or Founder Shares and that are held by the Sponsor, any Insider or any of their Permitted Transferees (that have complied with this paragraph 7(c)), are permitted (a) to the Company’s officers or directors, any
      affiliates or family members of any of the Company’s officers or directors, the Sponsor, any members of the Sponsor, or any affiliates of the Sponsor; (b) in the case of an individual, by gift to a member of the individual’s immediate family, or to a
      trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the
      individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of the initial Business Combination at prices no greater than the price at
      which the securities were originally purchased; (f) in the event of the Company’s liquidation prior to the completion of an initial Business Combination; (g) by virtue of the laws of the State of Delaware or the Sponsor’s limited liability company
      agreement upon dissolution of the Sponsor; or (h) in the event of the Company’s completion of a liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of the Company’s Public Stockholders having
      the right to exchange their shares of Common Stock for cash, securities or other property subsequent to the completion of the initial Business Combination (the transferees referred to in clauses (a)-(h) above are called “Permitted Transferees”); provided, however, that, in the case of clauses (a)-(e) and clause (g) above, these Permitted Transferees must enter into and deliver to the Company, at or prior to the time of the applicable Transfer, a
      written agreement agreeing to be bound by the transfer restrictions set forth in paragraph 3 and this paragraph 7 and the other provisions of this Letter Agreement applicable to Insiders.

    

    

    8.          The Sponsor and each Insider represent and warrant that it, he or she has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities or
      commodities license or registration denied, suspended or revoked. Each Insider’s biographical information furnished to the Company (including any such information included in the Prospectus) is true and accurate in all material respects and does not
      omit any material information with respect to the Insider’s background necessary to make such biographical information, in light of the circumstances in which such information is being presented in the Prospectus, not misleading. Each Insider’s
      questionnaire furnished to the Company is true and accurate in all material respects. Each Insider represents and warrants that: he or she is not subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order or
      stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; he or she has never been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any financial
      transaction or handling of funds of another person, or (iii) pertaining to any dealings in any securities and he or she is not currently a defendant in any such criminal proceeding.

    

    

    
      5

      
        

    

    

    

     

    9.          Except as disclosed in, or as expressly contemplated by, the Prospectus, neither the Sponsor nor any Insider nor any affiliate of the Sponsor or any Insider, nor any director or officer of the Company, shall
      receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any repayment of a loan or other compensation prior to, or in connection with, any services rendered in order to effectuate the consummation of the
      Company’s initial Business Combination (regardless of the type of transaction that it is). In the event that the Company shall issue any Working Capital Warrants upon conversion of any Working Capital Loans, not more than $1.5 million of such loans
      may be converted into Working Capital Warrants, such conversion shall only occur at or after the time the Business Combination is completed, the conversion price shall be $1.00 per Working Capital Warrant and such Working Capital Warrants shall be
      identical to the Private Placement Warrants, including, without limitation, as to exercise price, exercisability and exercise.

    

    

    10.          The Sponsor and each Insider has full right and power, without violating any agreement to which it, he or she is bound (including, without limitation, any non-competition or non-solicitation agreement with
      any employer or former employer), to enter into this Letter Agreement and, as applicable, to serve as an officer and/or a director on the board of directors of the Company and hereby consents to being named in the Prospectus as an officer and/or a
      director of the Company.

    

    

    11.          As used herein, (i) “Business Combination” shall mean a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
      combination, involving the Company and one or more businesses; (ii) “Capital Stock” shall mean, collectively, the Common Stock and the Founder Shares; (iii) “Founder Shares”
      shall mean the 5,750,000 outstanding shares of the Company’s Class B common stock, par value $0.0001 per share (up to 750,000 of which shares are subject to forfeiture if the Underwriter’s over-allotment option is not exercised by the Underwriter in
      whole or in part) (subject to adjustment to the numbers of shares in this clause (iii) pursuant to paragraph 5 of this Letter Agreement if the size of the Public Offering is increased or decreased); (iv) “Initial
        Stockholders” shall mean the Sponsor, the Insiders and any other holder of Founder Shares immediately prior to the consummation of the Public Offering; (v) “Private Placement Warrants” shall mean the
      warrants to purchase 9,560,000 shares of Common Stock (or up to 10,610,000 shares of Common Stock if the over-allotment option is exercised in full) that the Sponsor has agreed to purchase from the Company for an aggregate purchase price of
      $9,560,000 in the aggregate (or up to $10,610,000 if the over-allotment option is exercised in full), or $1.00 per warrant, in a private placement that shall occur simultaneously with the consummation of the Public Offering (subject to possible
      adjustment to the numbers of shares and dollar amounts (other than $1.00 per warrant) set forth in this clause (v) if the size of the Public Offering is increased or decreased); (vi) “Public Stockholders” shall
      mean the holders of Offering Shares; (vii) “Trust Account” shall mean the trust fund into which a portion of the net proceeds of the Public Offering and the sale of the Private Placement Warrants shall be
      deposited; and (viii) “Transfer” shall mean the (a) sale, transfer or assignment of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option to purchase or otherwise dispose of
      or agreement to dispose of, directly or indirectly, any Capital Stock, Private Placement Warrants or other securities of the Company, or the establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call
      equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to any Capital Stock, Private Placement Warrants or other securities of the Company, (b) entry into any swap or other arrangement
      that transfers to another, in whole or in part, any of the economic consequences of ownership of any Capital Stock, Private Placement Warrants or other securities of the Company, whether any such transaction described in clause (a) or (b) above is to
      be settled by delivery of Capital Stock, Private Placement Warrants or other securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).

    

    

    12.          This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations
      by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a
      typographical error) as to any particular provision, except by a written instrument executed by (1) each Insider that is the subject of any such change, amendment, modification or waiver, (2) the Sponsor and (3) the Company.

    

    

    
      6

      
        

    

    

    

     

    13.          Except as otherwise provided herein, no party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other parties.
      Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Company, the Sponsor and
      each Insider and their respective successors, heirs and assigns and Permitted Transferees.

    

    

    14.          Nothing in this Letter Agreement shall be construed to confer upon, or give to, any person or entity other than the parties hereto any right, remedy or claim under or by reason of this Letter Agreement or of
      any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises and agreements contained in this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto and their
      successors, heirs, personal representatives and assigns and Permitted Transferees.

    

    

    15.          This Letter Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but
      one and the same instrument. The words “executed”, “execution,” “signed,” “signature,” and words of like import in this Letter Agreement or in any certificate, agreement or document related to this Letter Agreement shall include images of manually
      executed signatures transmitted by facsimile, email or other electronic format (including, without limitation, “pdf,” “tif” or “jpg”) but shall not include (nor shall this Letter Agreement be executed by means of) electronic signatures (including,
      without limitation, DocuSign and AdobeSign). The use of signatures transmitted electronically and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by
      electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic
      Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform
      Commercial Code.

    

    

    16.          This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any
      other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend, to the extent permitted by applicable law, that there shall be added as a part of this Letter Agreement a
      provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

    

    

    17.          This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would result in the
      application of the substantive laws of another jurisdiction. To the extent permitted by applicable law, the parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement
      shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction
      and venue or that such courts represent an inconvenient forum.

    

    

    18.          Each party hereto shall not be liable for any breaches or misrepresentations contained in this Letter Agreement by any other party to this Letter Agreement (including, for the avoidance of doubt, any Insider
      with respect to any other Insider), and no party shall be liable or responsible for the obligations of another party, including, without limitation, indemnification obligations and notice obligations.

    

    

    19.          Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service,
      by certified mail (return receipt requested), by hand delivery or facsimile or other electronic transmission.

    

    

    20.          This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Periods or (ii) the liquidation of the Company; provided, however, that this Letter Agreement shall earlier terminate
      in the event that the Public Offering is not consummated and closed (other than any exercise of the over-allotment option) by March 31, 2022; provided further that paragraph 4 of this Letter Agreement shall survive such liquidation for a period of
      six years.

    

    

    [Signature Page Follows]

    

    

    
      7

      
        

    

    

    

     

    	
            Sincerely,

          	 
	 	 	 
	
            RJ HEALTHCARE SPAC, LLC

          	 
	 	 	 
	
            By:

          	 	 
	 	
            Name: Richard L. Jackson

          	 
	 	
            Title: Managing Member

          	 
	 	 	 
	
            Insiders

          	 
	 	 	 
	 	 
	
            Name: John Ellis “Jeb” Bush

          	 
	 	 	 
	 	 
	
            Name: Richard L. Jackson

          	 
	 	 	 
	 	 
	
            Name: Douglas B. Kline

          	 
	 	 	 
	 	 
	
            Name: David A. Perdue, Jr.

          	 
	 	 	 
	 	 
	
            Name: Marilyn B. Tavenner

          	 
	 	 	 
	 	 
	
            Name: Carlos A. Migoya

          	 

    

    

    
      
        

    

    

    

     

    	
            Acknowledged and Agreed:

          	 
	 	 	 
	
            JACKSON ACQUISITION COMPANY

          	 
	 	 	 
	
            By:

          	 	 
	 	
            Name: Richard L. Jackson

          	 
	 	
            Title:   President and Chief Executive Officer

          	 

    

    

    

    

    

    

    

    

    

    

    [Signature Page to Letter Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]